top of page
This site was designed with the
.com
website builder. Create your website today.Start Now

PUBLICATIONS

“The joy of discovery is certainly the liveliest that the mind of man can ever feel”

- Claude Bernard -

​

​

Google scholar citations

​

​​​

  1. Javonillo DI, Tran KM, Phan J, Hingco E,   Kramár EA, Cunha C, FORNER S, Kawauchi S, Milinkeviciute G,  Gomez-Arboledas  A,Neumann J, Banh CE, Huynh M, Matheos DP, Narges Rezaie N, Alcantara JA, Mortazavi AWood MA, ,Tenner AJ, MacGregor GR, Green KN and LaFerla FM Systematic Phenotyping and Characterization of the 3xTg-AD Mouse Model of Alzheimer’s Disease. Front. Neurosci., 24 January 2022, https://doi.org/10.3389/fnins.2021.785276

  2. Trujillo-Estrada L, Vanderklish PW, Nguyen MMT, Kuang RR, Nguyen C, Huynh E, da Cunha C, Javonillo DI, FORNER S, Martini AC, Sarraf ST, Simmon VF, Baglietto-Vargas D, LaFerla FM. SPG302 Reverses Synaptic and Cognitive Deficits Without Altering Amyloid or Tau Pathology in a Transgenic Model of Alzheimer's Disease. Neurotherapeutics. 2021 Nov 4. doi: 10.1007/s13311-021-01143-1.

  3. FORNER S, Kawauchi S, Balderrama-Gutierrez G, Kramár EA, Matheos DP, Phan J, Javonillo DI, Tran KM, Hingco E, da Cunha C, Rezaie N, Alcantara JA, Baglietto-Vargas D, Jansen C, Neumann J, Wood MA, MacGregor GR, Mortazavi A, Tenner AJ, LaFerla FM, Green KN.Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease. Sci Data. 2021 Oct 15;8(1):270. doi: 10.1038/s41597-021-01054-y.

  4. Baglietto-Vargas D, FORNER S, Cai L, Martini AC, Trujillo-Estrada L, , Jiang S, Kramár EA, Nuñez-Diaz C, Shahnawaz M, Matheos DP, Ma X, da Cunha C, Ager R R, Soto C, Gutierrez A, Moreno-Gonzalez I, MacGregor GR, Green KN, Wood MA, Mortazavi A, Tenner A J, LaFerla FM. Generation of a humanized Aβ expressing mouse demonstrating aspects of Alzheimer’s disease-like. Nat Commun 2021 Apr 23;12(1):2421. doi: 10.1038/s41467-021-22624-z

  5. Oblak AL, FORNER S, Territo PR, Sasner M, Carter GW, Howell GR, Sukoff-Rizzo SJ, Longsdon BA, Mangravite LM, Mortazavi A, Baglietto-Vargas D, Green KN, MacGregor GR, Wood MA, Tenner AJ, LaFerla FM, Lamb BT and the MODEL-AD Consortium. Model organism development and evaluation for late-onset Alzheimer’s disease: MODEL-AD. Alzheimers & Dementia: Translational Research & Clinical Interventions, Nov 2020.

  6. Rodriguez-Ortiz CJ, Prieto GA, Martini AC, FORNER S, Trujillo-Estrada L, LaFerla FM, Baglietto-Vargas D, Cotman CW, Kitazawa M. miR-181a negatively modulates synaptic plasticity in hippocampal cultures and its inhibition rescues memory deficits in a mouse model of Alzheimer's disease. Aging Cell. 2020 Mar;19(3):e13118. 

  7. FORNER S, Martini AC, Aleph Prieto G, Dang CT, Trujillo-Estrada L, da Cunha C, Andrews EJ, Phan J, Vu Ha J, Chang A V Z D, Levites Y, Cruz P E , Ager R R, Medeiros R, Cotman C W, GoldeT, Baglietto-Vargas D, LaFerla FM. Intra- and extracellular amyloid-β overexpression via adeno-associated virus-mediated gene transfer impairs memory and synaptic plasticity in the hippocampus Sci Rep. 2019 Nov 4;9(1):15936.

  8. Martini AC,  Gomez-Arboledas A, FORNER S, Rodriguez-Ortiz CJ, Phan J, Ha J-V, Trujillo-Estrada L, da Cunha C, Ager RR, Davila JC, Kitazawa M, Gutierrez A, Baglietto-Vargas D, Medeiros R, LaFerla FM. Amyloid-beta impairs TOM1-mediated IL-1R1 internalization and promotes Alzheimer’s disease progression. PNAS Oct 15;116(42):21198-21206.

  9. Trujillo-Estrada L, Gomez-Arboledas, FORNER S, Martini AC, Gutierrez A,  Baglietto-Vargas D, LaFerla FM. Astrocytes: From the Physiology to the Disease. Curr Alzheimer Res. Aug 30, 2019

  10. Trujillo-Estrada L, Nguyen C, da Cunha C, Cai L, FORNER S, Martini AC, Ager RR, Prieto GA, Cotman CW, Baglietto-Vargas D, LaFerla FM.Tau underlies synaptic and cognitive deficits for type 1, but not type 2 diabetes mouse models. Aging Cell. 2019 Feb 27:e12919. 

  11. Baglietto-Vargas D, Prieto GA, Limon A, FORNER S, Rodriguez-Ortiz CJ, Ikemura K, Ager RR, Medeiros R, Trujillo-Estrada L, Martini AC, Kitazawa M, Davila JC, Cotman CW, Gutierrez A, LaFerla FM. Impaired AMPA signaling and cytoskeletal alterations induce early synaptic dysfunction in a mouse model of Alzheimer's disease. Aging Cell. 2018 Jun 6:e12791.

  12. Martini AC, FORNER S, Trujillo-Estrada L, Baglietto-Vargas D, LaFerla FM. Past to future: what animal models have taught us about Alzheimer’s disease. J Alzheimers Dis. 2018;64(s1):S365-S378

  13. Vidal PM, Karadimas SK, Ulndreaj A, Laliberte AM, Tetreault L, FORNER S, Wang J, Foltz WD, Fehling MG. Delayed decompression exacerbates ischemia-reperfusion injury in cervical compressive myelopathy. JCI Insight. 2017 Jun 2;2(11).

  14. FORNER S, Baglietto-Vargas D, Martini AC, Trujjillo-Estrada L, LaFerla FM. Synaptic impairment in Alzheimer's Disease: a dysregulated symphony. Trends in Neuroscience. 2017 Jun;40(6):347-357.

  15. Melo FR, Bressan R, FORNER S, Martini AC, Rode M, Delben PB, Rae GA, Figueiredo C, Trentin A. Transplantation of Human Skin-Derived Mesenchymal Stromal Cells Improves Locomotor Recovery After Spinal Cord Injury in Rats.  (shared first-authorship). Cell Mol Neurobiol (2016)

  16. Martini AC, FORNER S, Koepp J, Rae GA. Inhibition of  spinal c-Jun-NH2-terminal kinase (JNK) improves locomotor activity of spinal cord injured rats. . Neuroscience Letters.  (2016)

  17. Martini AC, Berta T, FORNER S, Chen G, Bento AF, Ji RR, Rae GA. Lipoxin A4 inhibits microglial activation and reduces neuroinflammation and neuropathic pain after spinal cord hemisection. Journal of Neuroinflammation. (2016).

  18. FORNER S, Martini AC, Andrade EL, Rae GA. Spinal cord injury induced neuropathic pain: role of ETA and ETB endothelial receptors. Neuroscience Letters.  (2016).

  19. Matos AB, FORNER S, Martini AC, Patricio E, Clarke JR, Costa R, Felix-Alves J, Andrade EL, Calixto JB, Figueiredo C.  Temporal and regional expression of glucose-dependent insulinotropic peptide (GIP) and its receptor in spinal cord of rats following injury. Journal of Neurotrauma.   (shared first-authorship). (2016).​

  20. Martini AC, FORNER S, Bento AF, Rae GA. Neuroprotective effects of lipoxin A4 in central nervous system pathologies. BioMed Research International. (shared first-authorship). (2014)

  21. Assis LC; Hort MA; Souza GV; Martini AC; FORNER S; Martins DF; Silva JC; Horst H; Santos ARS; Pizzolatti MG; Rae GA; Koepp J; Bem AF; Valle RMR. Neuroprotective effect of the proanthocyanidin-rich fraction in experimental model of spinal cord injury. Journal of Pharmacy and Pharmacology. (2014)

  22. Meotti FC, FORNER S, Garcia JFL, Viana AF, Calixto JB. Antagonism of the transient receptor potential ankyrin 1 (TRPA1) attenuates hyperalgesia and urinary bladder overactivity in cyclophosphamide-induced haemorrhagic cystitis. Chemico-Biological Interactions  (2013).

  23. Pamplona FA, Ferreira J, Menezes de Lima O Jr, Duarte FS, Bento AF, FORNER S, Villarinho JG, Bellochio L, Wotjak CT, Lerner R, Monory K, Lutz B, Canetti C, Matias I, Calixto JB, Marsicano G, Guimarães MZ, Takahashi RN. Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor. Proc Natl Acad Sci U S A. (2012).

  24. Basei FL, Cabrini DA, Figueiredo CP, FORNER S, Hara DB, Nascimento AF, Ceravolo GS, Carvalho MH, Bader M, Medeiros R, Calixto JB.Endothelium dependent expression and underlying mechanisms of des-Arg9-bradykinin induced B1R-mediated vasoconstriction in rat portal vein. Peptides. (2012)

  25. FORNER S, Andrade EL, Martini AC, Bento AF, Medeiros R, Koepp J, Calixto JB. Effects of kinin B(1) and B(2) receptor antagonists on overactive urinary bladder syndrome induced by spinal cord injury in rats. British Journal Pharmacol. (2012).

  26. Andrade EL, FORNER S, Bento AF, Leite DF, Dias MA, Leal PC, Koepp J, Calixto JB. TRPA1 receptor modulation attenuates bladder overactivity induced by spinal cord injury. Am J Physiol Renal Physiol. (2011).

​

​

​

bottom of page